182 related articles for article (PubMed ID: 11015307)
1. Inhibition of small G proteins of the rho family by statins or clostridium difficile toxin B enhances cytokine-mediated induction of NO synthase II.
Hausding M; Witteck A; Rodriguez-Pascual F; von Eichel-Streiber C; Förstermann U; Kleinert H
Br J Pharmacol; 2000 Oct; 131(3):553-61. PubMed ID: 11015307
[TBL] [Abstract][Full Text] [Related]
2. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase.
Laufs U; Liao JK
J Biol Chem; 1998 Sep; 273(37):24266-71. PubMed ID: 9727051
[TBL] [Abstract][Full Text] [Related]
3. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
[TBL] [Abstract][Full Text] [Related]
4. Pitavastatin-induced thrombomodulin expression by endothelial cells acts via inhibition of small G proteins of the Rho family.
Masamura K; Oida K; Kanehara H; Suzuki J; Horie S; Ishii H; Miyamori I
Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):512-7. PubMed ID: 12615662
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B.
Kleinert H; Euchenhofer C; Ihrig-Biedert I; Förstermann U
Mol Pharmacol; 1996 Jan; 49(1):15-21. PubMed ID: 8569701
[TBL] [Abstract][Full Text] [Related]
6. Statins enhance toll-like receptor 4-mediated cytokine gene expression in astrocytes: implication of Rho proteins in negative feedback regulation.
Konat GW; Krasowska-Zoladek A; Kraszpulski M
J Neurosci Res; 2008 Feb; 86(3):603-9. PubMed ID: 17896797
[TBL] [Abstract][Full Text] [Related]
7. Cytokine induction of NO synthase II in human DLD-1 cells: roles of the JAK-STAT, AP-1 and NF-kappaB-signaling pathways.
Kleinert H; Wallerath T; Fritz G; Ihrig-Biedert I; Rodriguez-Pascual F; Geller DA; Förstermann U
Br J Pharmacol; 1998 Sep; 125(1):193-201. PubMed ID: 9776360
[TBL] [Abstract][Full Text] [Related]
8. Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability.
Massaro M; Zampolli A; Scoditti E; Carluccio MA; Storelli C; Distante A; De Caterina R
Cardiovasc Res; 2010 May; 86(2):311-20. PubMed ID: 19946014
[TBL] [Abstract][Full Text] [Related]
9. Statins potentiate the IFN-gamma-induced upregulation of group IIA phospholipase A2 in human aortic smooth muscle cells and HepG2 hepatoma cells.
Menschikowski M; Hagelgans A; Heyne B; Hempel U; Neumeister V; Goez P; Jaross W; Siegert G
Biochim Biophys Acta; 2005 Apr; 1733(2-3):157-71. PubMed ID: 15863363
[TBL] [Abstract][Full Text] [Related]
10. Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.
Mulhaupt F; Matter CM; Kwak BR; Pelli G; Veillard NR; Burger F; Graber P; Lüscher TF; Mach F
Cardiovasc Res; 2003 Sep; 59(3):755-66. PubMed ID: 14499877
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ.
Wagner AH; Schwabe O; Hecker M
Br J Pharmacol; 2002 May; 136(1):143-9. PubMed ID: 11976279
[TBL] [Abstract][Full Text] [Related]
12. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins).
Eberlein M; Heusinger-Ribeiro J; Goppelt-Struebe M
Br J Pharmacol; 2001 Aug; 133(7):1172-80. PubMed ID: 11487529
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of the immediate early gene product RhoB by exoenzyme C3 from Clostridium limosum and toxin B from Clostridium difficile.
Huelsenbeck J; Dreger SC; Gerhard R; Fritz G; Just I; Genth H
Biochemistry; 2007 Apr; 46(16):4923-31. PubMed ID: 17397186
[TBL] [Abstract][Full Text] [Related]
14. Modulation of COX-2 expression by statins in human aortic smooth muscle cells. Involvement of geranylgeranylated proteins.
Degraeve F; Bolla M; Blaie S; Créminon C; Quéré I; Boquet P; Lévy-Toledano S; Bertoglio J; Habib A
J Biol Chem; 2001 Dec; 276(50):46849-55. PubMed ID: 11591701
[TBL] [Abstract][Full Text] [Related]
15. Statins inhibit blastocyst formation by preventing geranylgeranylation.
Alarcon VB; Marikawa Y
Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
[TBL] [Abstract][Full Text] [Related]
16. Ras and RhoA suppress whereas RhoB enhances cytokine-induced transcription of nitric oxide synthase-2 in human normal liver AKN-1 cells and lung cancer A-549 cells.
Delarue FL; Taylor BS; Sebti SM
Oncogene; 2001 Oct; 20(45):6531-7. PubMed ID: 11641777
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR/S6 kinase activity.
Finlay GA; Malhowski AJ; Liu Y; Fanburg BL; Kwiatkowski DJ; Toksoz D
Cancer Res; 2007 Oct; 67(20):9878-86. PubMed ID: 17942919
[TBL] [Abstract][Full Text] [Related]
18. Potentiated cytotoxic effects of statins and ajoene in murine melanoma cells.
Ledezma E; Wittig O; Alonso J; Cardier JE
Melanoma Res; 2009 Apr; 19(2):69-74. PubMed ID: 19276863
[TBL] [Abstract][Full Text] [Related]
19. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes.
Assmus B; Urbich C; Aicher A; Hofmann WK; Haendeler J; Rössig L; Spyridopoulos I; Zeiher AM; Dimmeler S
Circ Res; 2003 May; 92(9):1049-55. PubMed ID: 12676819
[TBL] [Abstract][Full Text] [Related]
20. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages.
Pahan K; Sheikh FG; Namboodiri AM; Singh I
J Clin Invest; 1997 Dec; 100(11):2671-9. PubMed ID: 9389730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
